Published in Arthritis Rheum on December 01, 2007
Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis. PLoS One (2012) 1.63
Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial. Ann Rheum Dis (2012) 1.04
The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses. Arthritis Res Ther (2011) 1.04
Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan. Clin Exp Rheumatol (2009) 1.02
Can bone loss in rheumatoid arthritis be prevented? Osteoporos Int (2013) 1.02
What magnetic resonance imaging has told us about the pathogenesis of rheumatoid arthritis--the first 50 years. Arthritis Res Ther (2008) 0.95
Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years. Ann Rheum Dis (2011) 0.94
Role of magnetic resonance imaging in the diagnosis and prognosis of rheumatoid arthritis. Arthritis Care Res (Hoboken) (2011) 0.90
The impact of MRI on the clinical management of inflammatory arthritides. Skeletal Radiol (2011) 0.88
The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy. Ann Rheum Dis (2014) 0.85
Infliximab in the treatment of rheumatoid arthritis. Biologics (2009) 0.79
Infection Risk and Safety of Corticosteroid Use. Rheum Dis Clin North Am (2015) 0.78
Methotrexate dosage as a source of bias in biological trials in rheumatoid arthritis: a systematic review. Ann Rheum Dis (2016) 0.78
Leveling the field in the treatment of rheumatoid arthritis with biologic therapies: equal access for equal efficacy. Clin Rheumatol (2009) 0.78
Effects of dexamethasone, celecoxib, and methotrexate on the histology and metabolism of bone tissue in healthy Sprague Dawley rats. Clin Interv Aging (2015) 0.76
Systematic review and network meta-analysis of the efficacy and safety of tumour necrosis factor inhibitor-methotrexate combination therapy versus triple therapy in rheumatoid arthritis. RMD Open (2017) 0.75
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum (2002) 3.96
Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med (2008) 3.89
Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum (2007) 2.45
Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Am J Sports Med (2009) 2.32
The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol (2010) 2.21
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial. Ann Rheum Dis (2010) 2.09
Which B-cell subset should we target in lupus? Ann Rheum Dis (2013) 2.03
A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum (2010) 2.02
Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum (2006) 2.01
Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol (2003) 1.99
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum (2004) 1.89
Detection of antinuclear antibodies by automated indirect immunofluorescence analysis. Clin Chim Acta (2012) 1.88
Osteoarthritis and osteoporosis: clinical and research evidence of inverse relationship. Aging Clin Exp Res (2003) 1.75
Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22. Ann Rheum Dis (2010) 1.75
Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest (2005) 1.73
Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate. Arthritis Rheum (2008) 1.73
Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum (2003) 1.67
Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis. Arthritis Rheum (2009) 1.62
Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum (2007) 1.61
Tight regulation of wingless-type signaling in the articular cartilage - subchondral bone biomechanical unit: transcriptomics in Frzb-knockout mice. Arthritis Res Ther (2012) 1.52
Evaluation of rotator cuff tendon tears: comparison of multidetector CT arthrography and 1.5-T MR arthrography. Radiology (2012) 1.49
Engineering vascularized bone: osteogenic and proangiogenic potential of murine periosteal cells. Stem Cells (2012) 1.49
Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis. Am J Hum Genet (2008) 1.45
Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis. Arthritis Res Ther (2009) 1.42
Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Chem (2007) 1.37
Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. Arthritis Rheum (2004) 1.34
Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: early treatment matters. Am J Sports Med (2011) 1.31
Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc Natl Acad Sci U S A (2007) 1.29
Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis. Proc Natl Acad Sci U S A (2012) 1.28
Developmental engineering: a new paradigm for the design and manufacturing of cell-based products. Part I: from three-dimensional cell growth to biomimetics of in vivo development. Tissue Eng Part B Rev (2009) 1.26
Cartilage repair: past and future--lessons for regenerative medicine. J Cell Mol Med (2009) 1.24
Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis. Arthritis Res Ther (2009) 1.23
Uncommon magnetic resonance imaging observation of lumbar subdural hematoma with cranial origin. J Comput Assist Tomogr (2003) 1.21
End plate marrow changes in the asymptomatic lumbosacral spine: frequency, distribution and correlation with age and degenerative changes. Skeletal Radiol (2004) 1.21
Inhibition of inflammation but not ankylosis by glucocorticoids in mice: further evidence for the entheseal stress hypothesis. Arthritis Res Ther (2012) 1.20
Donor site morbidity after articular cartilage repair procedures: a review. Acta Orthop Belg (2010) 1.14
Quantification of lung fibrosis and emphysema in mice using automated micro-computed tomography. PLoS One (2012) 1.14
Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid. Arthritis Rheum (2013) 1.13
Biological aspects of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc (2011) 1.13
Effects of MRI contrast agents on the stem cell phenotype. Cell Transplant (2010) 1.13
Contemporary concepts of inflammation, damage and repair in rheumatic diseases. Best Pract Res Clin Rheumatol (2006) 1.13
The ITGAV rs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study. Arthritis Res Ther (2007) 1.12
Bone morphogenetic protein signaling in joint homeostasis and disease. Cytokine Growth Factor Rev (2005) 1.11
Bone marrow edema of the femoral head and transient osteoporosis of the hip. Eur J Radiol (2008) 1.11
Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort. Arthritis Rheumatol (2015) 1.09
Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmun Rev (2012) 1.07
Multidetector spiral CT arthrography of the shoulder. Clinical applications and limits, with MR arthrography and arthroscopic correlations. Eur J Radiol (2008) 1.07
Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis. Arthritis Rheum (2006) 1.07
Bcl11a is required for neuronal morphogenesis and sensory circuit formation in dorsal spinal cord development. Development (2012) 1.07
GDF5 deficiency in mice is associated with instability-driven joint damage, gait and subchondral bone changes. Ann Rheum Dis (2010) 1.07
The combined bone forming capacity of human periosteal derived cells and calcium phosphates. Biomaterials (2011) 1.07
A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum (2008) 1.06
Autologous chondrocyte implantation versus microfracture for knee cartilage injury: a prospective randomized trial, with 2-year follow-up. Knee Surg Sports Traumatol Arthrosc (2009) 1.06
The Noggin null mouse phenotype is strain dependent and haploinsufficiency leads to skeletal defects. Dev Dyn (2006) 1.06
Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients. Clin Rheumatol (2007) 1.05
Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study. Arthritis Rheum (2013) 1.04
Optimal care for early RA patients: the challenge of translating scientific data into clinical practice. Rheumatology (Oxford) (2011) 1.04
Microenvironment and phenotypic stability specify tissue formation by human articular cartilage-derived cells in vivo. Exp Cell Res (2003) 1.04
Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology. J Cell Mol Med (2011) 1.03
Expanded phenotypically stable chondrocytes persist in the repair tissue and contribute to cartilage matrix formation and structural integration in a goat model of autologous chondrocyte implantation. J Orthop Res (2003) 1.01
Xenopus SMOC-1 Inhibits bone morphogenetic protein signaling downstream of receptor binding and is essential for postgastrulation development in Xenopus. J Biol Chem (2009) 1.00
A 3'-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus. Arthritis Rheum (2010) 0.99
Multi-detector CT imaging in the postoperative orthopedic patient with metal hardware. Eur J Radiol (2006) 0.99
Effectiveness of an integrated outpatient care programme compared with present-day standard care in early rheumatoid arthritis. Musculoskeletal Care (2009) 0.98
Probing the osteoinductive effect of calcium phosphate by using an in vitro biomimetic model. Tissue Eng Part A (2011) 0.98
Species specificity of ectopic bone formation using periosteum-derived mesenchymal progenitor cells. Tissue Eng (2006) 0.98
(18)F-fluoride PET for monitoring therapeutic response in Paget's disease of bone. J Nucl Med (2005) 0.98
The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes. Hum Genet (2010) 0.97
Mechanisms of ectopic bone formation by human osteoprogenitor cells on CaP biomaterial carriers. Biomaterials (2012) 0.95
Current management of lupus nephritis. Best Pract Res Clin Rheumatol (2013) 0.93
Gait characteristics and lower limb muscle strength in women with early and established knee osteoarthritis. Clin Biomech (Bristol, Avon) (2012) 0.93
Assessment of knee cartilage in cadavers with dual-detector spiral CT arthrography and MR imaging. Radiology (2002) 0.93
Fine mapping and conditional analysis identify a new mutation in the autoimmunity susceptibility gene BLK that leads to reduced half-life of the BLK protein. Ann Rheum Dis (2012) 0.92
Dependence on interferon-gamma for the spontaneous occurrence of arthritis in DBA/1 mice. Arthritis Rheum (2003) 0.92
The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases. Arthritis Res Ther (2007) 0.92
Noggin null allele mice exhibit a microform of holoprosencephaly. Hum Mol Genet (2011) 0.92
The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype. Ann Rheum Dis (2010) 0.92
Meniscal tears with fragments displaced in notch and recesses of knee: MR imaging with arthroscopic comparison. Radiology (2005) 0.92
Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev (2011) 0.91
Value of computed tomography arthrography with delayed acquisitions in the work-up of ganglion cysts of the tarsal tunnel: report of three cases. Skeletal Radiol (2010) 0.91
Molecular imaging of rheumatoid arthritis: emerging markers, tools, and techniques. Arthritis Res Ther (2014) 0.91
18F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastructure and differentiation capacity. J Nucl Med (2013) 0.91
Clinical images: voriconazole-induced periostitis deformans. Arthritis Rheum (2012) 0.90
Testing for the association of the KIAA1109/Tenr/IL2/IL21 gene region with rheumatoid arthritis in a European family-based study. Arthritis Res Ther (2009) 0.90
Spontaneous rupture of the distal iliopsoas tendon: clinical and imaging findings, with anatomic correlations. Eur Radiol (2005) 0.90
Polygonal deformation of the dural sac in lumbar epidural lipomatosis: anatomic explanation by the presence of meningovertebral ligaments. AJNR Am J Neuroradiol (2003) 0.90
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial. Nephrol Dial Transplant (2011) 0.90
Indications for a genetic association of a VCP polymorphism with the pathogenesis of sporadic Paget's disease of bone, but not for TNFSF11 (RANKL) and IL-6 polymorphisms. Mol Genet Metab (2011) 0.90
Polymyalgia Rheumatica (PMR) Special Interest Group at OMERACT 11: outcomes of importance for patients with PMR. J Rheumatol (2014) 0.90